TOPIC
4 Stories Published
Clinical Trials
FDA Approval for Gene Therapy: The Path From Trial to License
FDA approval for gene therapy runs through an IND, phased trials and a Biologics License Application. Here is each step, the expedited…
In Vivo Gene Editing in October 2026: What the Human Data Actually Show
One phase 3 win in hereditary angioedema, early cholesterol and AATD data, and a fatal liver event in a paused trial: a…
AI-Designed Drugs in Clinical Trials: What Has Actually Been Shown
Rentosertib began phase 3 in September 2026, but no AI-designed drug has completed one. Here is what the trials, registries and success-rate…
In Vivo CAR-T Explained: Making CAR T Cells Inside the Body, and What the 2026 Data Really Show
One infusion, no factory: how in vivo CAR-T turns a patient's own T cells into cancer fighters, and what small 2026 trials…
